Search Results - "Gröndal, Gerður"

Refine Results
  1. 1

    Giant cell arteritis: a case report with scalp necrosis and sudden blindness by Árnadóttir, Berglind, Gröndal, Gerður, Tryggvason, Þórður, Guðbjörnsson, Björn

    Published in Laeknabladid (04-12-2021)
    “…In the summer of 2020, an elderly woman in her eighties sought medical attention due to headache and visual disturbances. The diagnosis was unclear, she became…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Approved and unapproved use of immunoglobulins in Iceland by Ólafsdóttir, Bryndís Ester, BSc, Þorsteinsson, Davíð Þór, MD, Einarsdóttir, Rannveig, MSc, Lúðvíksson, Björn Rúnar, MD, PhD, Gröndal, Gerður, MD, Erlendsson, Kristján, MD, Haraldsson, Ásgeir, MD, PhD

    Published in Journal of allergy and clinical immunology (01-06-2013)
    “…To the Editor: Immunoglobulin therapy has been increasingly used in the treatment of various diseases for decades.1-5 Congenital or acquired immunodeficiency,…”
    Get full text
    Journal Article
  4. 4

    Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor Antagonists by Björnsson, Einar S, Gunnarsson, Baldvin I, Gröndal, Gerdur, Jonasson, Jon G, Einarsdottir, Rannveig, Ludviksson, Björn R, Gudbjörnsson, Björn, Olafsson, Sigurdur

    Published in Clinical gastroenterology and hepatology (01-03-2015)
    “…Background & Aims Antagonists of tumor necrosis factor (anti-TNF agents) can cause drug-induced liver injury (DILI), yet little is known about the level of…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth? by Putrik, Polina, Ramiro, Sofia, Kvien, Tore K, Sokka, Tuulikki, Uhlig, Till, Boonen, Annelies

    Published in Annals of the rheumatic diseases (01-11-2014)
    “…To explore criteria regulating treatment with reimbursed biologic disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA)…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018 by Kristjánsson, Valdimar B., Lund, Sigrún H., Gröndal, Gerður, Sveinsdóttir, Signý V., Agnarsson, Hjálmar R., Jónasson, Jón G., Björnsson, Einar S.

    Published in Scandinavian journal of gastroenterology (02-01-2021)
    “…Immune-mediated diseases are on the rise after the introduction of powerful immunomodulating drugs. The objective of this study was to determine the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Nationwide prevalence of glucocorticoid prescriptions over 17 years and osteoporosis prevention among long-term users by Bjornsdottir, Hulda Hrund, Einarsson, Ólafur Brynjólfur, Gröndal, Gerdur, Gudbjornsson, Bjorn

    Published in SAGE open medicine (01-01-2024)
    “…Glucocorticoid steroids are frequently prescribed, and side effects are well-known, such as glucocorticoid-induced osteoporosis. Our aim was to estimate the…”
    Get full text
    Journal Article
  16. 16

    Drivers of costly treatment strategies in rheumatoid arthritis by Huizinga, Tom W J, Gröndal, Gerdur

    Published in The Lancet (British edition) (16-07-2016)
    “…In view of the scarcity of evidence on treatment strategies using expensive drugs in rheumatoid arthritis, some friction often occurs between the wish of…”
    Get full text
    Journal Article
  17. 17

    Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study by Knevel, Rachel, Gröndal, Gerður, Huizinga, Tom W J, Visser, A Willemien, Jónsson, Helgi, Víkingsson, Arnór, Geirsson, Arni Jón, Steinsson, Kristján, van der Helm-van Mil, Annette H M

    Published in Annals of the rheumatic diseases (01-05-2012)
    “…The susceptibility to rheumatoid arthritis (RA) is partly heritable, but whether the severity of RA is also influenced by genetics has not been determined. The…”
    Get more information
    Journal Article
  18. 18
  19. 19

    A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program by Karlsdottir, Kristin, Gunnarsdottir, Anna I, Grondal, Gerdur, Love, Thorvardur J, Stefansdottir, Elinborg, Davidsdottir, Loa G, Thorleifsdottir, Ragna H, Gudbjornsson, Bjorn

    Published in Frontiers in medicine (27-01-2022)
    “…Due to a tender process in Iceland, all patients on Humira® were switched nationwide to its biosimilar Imraldi® in March 2019. The study aimed to explore the…”
    Get full text
    Journal Article
  20. 20

    Inequities in access to biologic and synthetic DMARDs across 46 European countries by Putrik, Polina, Ramiro, Sofia, Kvien, Tore K, Sokka, Tuulikki, Pavlova, Milena, Uhlig, Till, Boonen, Annelies

    Published in Annals of the rheumatic diseases (01-01-2014)
    “…We investigated access to biologic and synthetic disease modifying drugs (bDMARDs and sDMARDs) in patients with rheumatoid arthritis (RA) across Europe. A…”
    Get more information
    Journal Article